Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

To the Editor: A 45-year-old man with severe antiphospholipid syndrome complicated by diffuse alveolar hemorrhage, who was receiving anticoagulation therapy, glucocorticoids, cyclophosphamide, and intermittent rituximab and eculizumab, was admitted to the hospital with fever (Fig. S1 in the…

Leave a Reply

Your email address will not be published. Required fields are marked *